Oryzon Genomics

Oryzon

Contact information

Oryzon Genomics SA
Carlos Buesa, CEO
C / Sant Ferran 74
Cornellà de Llobregat
Barcelona
935151313
933774028
Areas of activity
  • A. Health Biotechnology
  • A. Health Biotechnology
  • Therapeutic areas
  • A. Health Biotechnology
  • Therapeutic areas
  • Oncology
  • A. Health Biotechnology
  • Therapeutic areas
  • Central nervous system
  • A. Health Biotechnology
  • Areas of activity
  • A. Health Biotechnology
  • Areas of activity
  • In vitro diagnostics
  • B. Agrifood Biotechnology
  • B. Agrifood Biotechnology
  • Agriculture / veterinary / environmental
  • B. Agrifood Biotechnology
  • Agriculture / veterinary / environmental
  • Other enhancement techniques (molecular marker..)
  • D. Services
  • D. Services
  • R&D services
  • D. Services
  • R&D services
  • Bioinformatics
  • D. Services
  • R&D services
  • Biotechnolgy kits
  • D. Services
  • R&D services
  • Genomics
  • D. Services
  • R&D services
  • Proteomics

Oryzon is a biomarker discovery company with a Diagnostic and Therapeutic pipeline focused in Oncology and Neurological disorders. Oryzon's mission is the identification of gene functions and proteins so as to design and develop biotechnological products that improve people's health.

Products and services

The company has an integrated bio-marker discovery and validation platform and develops its own core research program, with an increasing number of projects in selected niches of the biomedicine arena always in partnership with the Academia and Pharmaceutical companies.

Areas of interest for future collaborations

Oryzon has several important strategic alliances with food, biotech and pharmaceutical companies and is looking for industrial pharma and food partners to launch new global projects.